pre-IPO PHARMA

COMPANY OVERVIEW

Immatics is a leading cancer immunotherapy company and the global leader in the discovery of novel targets for various types of cancer immunotherapies.


LOCATION

  • Tübingen, , Germany
  • Houston, TX, USA
  • Martinsried/Planegg, , Germany

  • THERAPEUTIC AREAS

  • Immunology
  • Oncology

  • WEBSITE

    https://immatics.com/


    CAREER WEBSITE

    https://immatics.com/careers/


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Jul 7, 2021

    BioCopy AG und Immatics Biotechnologies GmbH verkünden Kollaboration im Bereich T-Zell Rezeptor - Peptid HLA Charakterisierung USA - English USA - English France - Français


    For More Press Releases


    Google Analytics Alternative